Xiaoxiao Wang

3PUBLICATIONS
22CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

Sort by Publication Date:
|Oct 23, 2026
Frontline Bruton tyrosine kinase inhibitors are associated with improved response and PFS in primary CNS lymphoma.

|Feb 11, 2025
Metabolic parameter of baseline 18 F-FDG PET/CT with PINK models improve the prediction of treatment outcome in extranodal NK/T-cell lymphoma treated with P-GEMOX chemotherapy.

Cheng Huang, Yi Li, Haixia He

|Feb 06, 2025
High-Dose Methotrexate, Ibrutinib, and Temozolomide in the Treatment of Newly Diagnosed Primary CNS Lymphoma: A Multicenter, Prospective Phase II Study.

Yan Gao, Liqin Ping, Changguo Shan

Pageof 1

Frequent Collaborators

2 joint publications

Cheng Huang

1 joint publications

Yan Gao

1 joint publications

Liqin Ping

1 joint publications

Changguo Shan

1 joint publications

He Huang

1 joint publications

Zhiming Li

1 joint publications

Hui Zhou

1 joint publications

Mingyao Lai

1 joint publications

Linbo Cai

1 joint publications

Bing Bai

Frequent Collaborators

2 joint publications

Cheng Huang

1 joint publications

Yan Gao

1 joint publications

Liqin Ping

1 joint publications

Changguo Shan

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us